223 related articles for article (PubMed ID: 9299614)
1. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
Chen JJ; Hong Y; Androphy EJ
Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
[TBL] [Abstract][Full Text] [Related]
2. Bovine papillomavirus type 1 E6-induced sensitization to apoptosis is distinct from its transforming activity.
Liu Z; Liu Y; Hong Y; Rapp L; Androphy EJ; Chen JJ
Virology; 2002 Apr; 295(2):230-7. PubMed ID: 12033781
[TBL] [Abstract][Full Text] [Related]
3. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
Hines CS; Meghoo C; Shetty S; Biburger M; Brenowitz M; Hegde RS
J Mol Biol; 1998 Mar; 276(4):809-18. PubMed ID: 9500925
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
[TBL] [Abstract][Full Text] [Related]
5. The BPV-1 E2 DNA-contact helix cysteine is required for transcriptional activation but not replication in mammalian cells.
Grossel MJ; Barsoum J; Prakash SS; Androphy EJ
Virology; 1996 Mar; 217(1):301-10. PubMed ID: 8599215
[TBL] [Abstract][Full Text] [Related]
6. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
Mansur CP; Marcus B; Dalal S; Androphy EJ
Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
[TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.
Pim D; Massimi P; Banks L
Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760
[TBL] [Abstract][Full Text] [Related]
8. The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis.
Rapp L; Liu Y; Hong Y; Androphy EJ; Chen JJ
Oncogene; 1999 Jan; 18(3):607-15. PubMed ID: 9989810
[TBL] [Abstract][Full Text] [Related]
9. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.
Patel D; Huang SM; Baglia LA; McCance DJ
EMBO J; 1999 Sep; 18(18):5061-72. PubMed ID: 10487758
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
Pim D; Storey A; Thomas M; Massimi P; Banks L
Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
[TBL] [Abstract][Full Text] [Related]
12. Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.
Das K; Bohl J; Vande Pol SB
J Virol; 2000 Jan; 74(2):812-6. PubMed ID: 10623743
[TBL] [Abstract][Full Text] [Related]
13. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
O'Brien V; Campo MS
Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
[TBL] [Abstract][Full Text] [Related]
14. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
15. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6.
Inoue T; Oka K; Yong-Il H; Vousden KH; Kyo S; Jing P; Hakura A; Yutsudo M
Mol Carcinog; 1998 Mar; 21(3):215-22. PubMed ID: 9537653
[TBL] [Abstract][Full Text] [Related]
16. Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription.
Trujillo JM; Mounts P
Virology; 1996 Jun; 220(1):1-9. PubMed ID: 8659100
[TBL] [Abstract][Full Text] [Related]
17. A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.
O'Brien V; Ashrafi GH; Grindlay GJ; Anderson R; Campo MS
Virology; 1999 Mar; 255(2):385-94. PubMed ID: 10069964
[TBL] [Abstract][Full Text] [Related]
18. Modulation of transcriptional regulatory properties of p53 by HPV E6.
Crook T; Fisher C; Masterson PJ; Vousden KH
Oncogene; 1994 Apr; 9(4):1225-30. PubMed ID: 8134125
[TBL] [Abstract][Full Text] [Related]
19. HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation.
Thomas M; Massimi P; Jenkins J; Banks L
Oncogene; 1995 Jan; 10(2):261-8. PubMed ID: 7838526
[TBL] [Abstract][Full Text] [Related]
20. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
